A prespecified analysis of the MASTER DAPT trial has confirmed that the absence of ischemic risk and reduction in bleeding with abbreviated dual antiplatelet therapy (DAPT) in patients at high bleeding risk undergoing intervention ...
Aug 29, 2022
0
9
The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischemic heart disease, according to late breaking research ...
Aug 29, 2022
0
0
Basic life support training in schools and communities is essential to improve survival from cardiac arrest, according to European Society of Cardiology (ESC) Guidelines published online today in the European Heart Journal. ...
Aug 26, 2022
0
5
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
Aug 22, 2022
0
4
For patients with end-stage renal disease (ESRD), those with concomitant psoriasis are younger and more often have cancer, diabetes mellitus, and coronary artery disease, according to a study published online July 26 in the ...
Aug 18, 2022
0
6
Significant differences in initial heart attack diagnosis and treatment were found among Black and Hispanic adults compared to white adults, according to new research published in the open access, peer-reviewed Journal of ...
Jul 27, 2022
0
2
Hormone therapy for prostate cancer increases the risk of cardiovascular disease-related death especially in older men, according to a population study involving more than 13,000 patients.
Jul 27, 2022
0
17
Forget what you thought you knew about catching COVID-19 more than once. SARS-CoV-2, the virus that causes COVID-19, keeps evolving—and so has information about your risk of being reinfected.
Jul 20, 2022
0
17
Patients over age 80 are considered high-risk candidates for coronary artery bypass grafting, not only because of normal wear and tear on the body, but also because of comorbidities and risks of complications after surgery. ...
Jun 20, 2022
0
4
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound ...
Jun 14, 2022
0
8
